PEAK6’s Medifast MED Stock Holding History

PEAK6’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$918K	Sell	90,100 -18,600	-17%	-$201K	﹤0.01%	1740
2025 Q4	$1.16M	Sell	108,700 -297,200	-73%	-$3.56M	﹤0.01%	1698
2025 Q3	$5.55M	Buy	405,900 +104,200	+35%	+$1.46M	0.01%	982
2025 Q2	$4.24M	Buy	+301,700	New	+$3.96M	0.01%	1047

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

PEAK6's MED Position: Q1 2026 in Review

PEAK6 sold out of Medifast (MED) in Q1 2026, closing a stake of 7,426 shares — an estimated $80.1K sold.

PEAK6 first reported a position in MED in Q4 2025 and held it in 1 quarter. The position peaked at $79.3K in Q4 2025. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

PEAK6 reported no remaining Medifast position as of Q1 2026 after selling out during the quarter.
PEAK6 sold 7,426 Medifast shares in Q1 2026, an estimated $80.1K.
PEAK6 first reported a position in Medifast in Q4 2025 and held it in 1 quarter.
PEAK6's Medifast position peaked at $79.3K in Q4 2025.
111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.